Neumora Therapeutics, Inc. Interest Expense, Debt
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2026-08-14
- Neumora Therapeutics, Inc. interest expense, debt for the quarter ending 2026-06-30 was $1.82M, a 317.43% increase year-over-year.
- Neumora Therapeutics, Inc. interest expense, debt for the quarter ending 2026-03-31 was $1.85M.
- Neumora Therapeutics, Inc. interest expense, debt for the quarter ending 2025-06-30 was $436.00K.
- Neumora Therapeutics, Inc. interest expense, debt for fiscal 2025 was $3.22M.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 12 month |
|---|---|---|---|
| 2026-06-30 | $1.82M 10-Q · filed 2026-08-14 | $3.67M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.85M 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $3.22M 10-K · filed 2026-03-30 | ||
| 2025-06-30 | $436.00K 10-Q · filed 2026-08-14 | $436.00K 10-Q · filed 2026-08-14 |